Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.46 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.46 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.46 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | CASP7 | P55210 | 1/20 | 0.37 |
| ▸ | HBB | P68871 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Naphthalene SCHEMBL6925512 | 0.89 | CYP2A6 (0.47) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Phenanthrene SCHEMBL27901311 | 0.80 | ALDH1A1 (0.57) | ALOX15TDP1ALDH1A1HSD17B10HIF1A | |
| Maleic Anhydride SCHEMBL5638360 | 0.76 | ALOX15 (0.39) | HSP90AA1ALOX15TDP1ALDH1A1HSD17B10 | |
| Maleic Anhydride SCHEMBL1761076 | 0.76 | ALDH1A1 (0.37) | HSP90AA1ALOX15TDP1ALDH1A1HSD17B10 | |
| Maleic Anhydride SCHEMBL10482080 | 0.76 | ALDH1A1 (0.37) | HSP90AA1ALOX15TDP1ALDH1A1HSD17B10 | |
| Maleic Anhydride SCHEMBL1332543 | 0.76 | — | — | |
| Maleic Anhydride SCHEMBL10482026 | 0.76 | ALDH1A1 (0.37) | HSP90AA1ALOX15TDP1ALDH1A1HSD17B10 | |
| Maleic Anhydride SCHEMBL1332137 | 0.76 | — | — | |
| Maleic Anhydride SCHEMBL1332547 | 0.76 | — | — | |
| Maleic Anhydride SCHEMBL191 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10640466-B2 | Anthracene based compounds and their uses | UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION (GB) | 2020-05-05 | — | — | US | disclosed |
| US-20180118685-A1 | ANTHRACENE BASED COMPOUNDS AND THEIR USES | UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION (GB) | 2018-05-03 | — | — | US | disclosed |
| EP-3294730-A1 | ANTHRACENE BASED COMPOUNDS AND THEIR USES | University of Hertfordshire Higher Education Corporation (GB) | 2018-03-21 | — | — | EP | disclosed |
| WO-2016181120-A1 | ANTHRACENE BASED COMPOUNDS AND THEIR USES | UNIVERSITY OF HERTFORDSHIRE HIGHER EDUCATION CORPORATION (GB) | 2016-11-17 | — | — | WO | disclosed |
| US-5025222-A | System and method for monitoring substances and reactions | PHASE DYNAMICS, INC. (US) | 1991-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118685-A1 | ANTHRACENE BASED COMPOUNDS AND THEIR USES | CYP2D6, CYP3A43, ACMSD | GRIN2D 3356/4885GRIN3B 3059/4885GRIN1 4255/4885 |
| US-10640466-B2 | Anthracene based compounds and their uses | CYP2D6, CYP3A43, ACMSD | GRIN2D 3356/4885GRIN3B 3059/4885GRIN1 4255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.